Alzecure Pharma Stock Filter Stocks by Fundamentals
| ALZCUR Stock | SEK 1.19 0.16 15.53% |
AlzeCure Pharma fundamentals help investors to digest information that contributes to AlzeCure Pharma's financial success or failures. It also enables traders to predict the movement of AlzeCure Stock. The fundamental analysis module provides a way to measure AlzeCure Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AlzeCure Pharma stock.
AlzeCure |
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
AlzeCure Fundamentals
| Return On Equity | -1.55 | |||
| Return On Asset | -0.78 | |||
| Current Valuation | 173.51 M | |||
| Shares Outstanding | 59.19 M | |||
| Shares Owned By Insiders | 41.31 % | |||
| Shares Owned By Institutions | 6.48 % | |||
| Price To Book | 6.62 X | |||
| EBITDA | (77.2 M) | |||
| Net Income | (77.78 M) | |||
| Cash And Equivalents | 222.05 M | |||
| Cash Per Share | 5.88 X | |||
| Current Ratio | 48.05 X | |||
| Book Value Per Share | 0.63 X | |||
| Cash Flow From Operations | (70.64 M) | |||
| Earnings Per Share | (1.78) X | |||
| Target Price | 11.88 | |||
| Number Of Employees | 14 | |||
| Beta | 0.76 | |||
| Market Capitalization | 254.44 M | |||
| Total Asset | 45.65 M | |||
| Z Score | -3.3 | |||
| Net Asset | 45.65 M |
About AlzeCure Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AlzeCure Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AlzeCure Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AlzeCure Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in AlzeCure Stock
AlzeCure Pharma financial ratios help investors to determine whether AlzeCure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzeCure with respect to the benefits of owning AlzeCure Pharma security.